Simplified Co-extraction of total Nucleic Acids from Respiratory Samples for detection of <i>Mycobacterium tuberculosis</i> and SARS-CoV-2 optimized for compatibility across Diagnostic Platforms.
Ontology highlight
ABSTRACT: Tuberculosis (TB) and COVID-19 are leading infectious diseases with high mortality, caused by Mycobacterium tuberculosis (Mtb) and SARS-CoV-2 (SC2), respectively. Co-infection is common but is often undiagnosed as it is challenging to process both pathogens from a single sample. In this study, we present a simple and efficient method for co-extracting nucleic acids (NA) from these two distinct respiratory pathogens for downstream diagnostic testing. We evaluated three different nucleic acid amplification (NAA)-based platforms, LightCycler480 (LC480) qPCR, Qiacuity digital PCR (dPCR), and Cytation3 for CRISPR-Cas13a-based SHINE-TB/SC2 detection assays. Chelex-100 chelating resin-based boiling preparation method was optimized for Mtb NA extraction from saliva and sputum.
SUBMITTER: Modi NH
PROVIDER: S-EPMC11908299 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA